Echocardiogram Validity Duration

Validity by Specific Cardiac Conditions

• The European Society of Cardiology recommends follow-up at 6 months after initial assessment for asymptomatic severe aortic regurgitation, then yearly if stable 1
• For mild or moderate aortic regurgitation, the European Society of Cardiology recommends follow-up every 2 years 1
• The European Society of Cardiology recommends annual echocardiography for severe mitral stenosis 1
• For mitral stenosis with valve area ≥1.5 cm², the European Society of Cardiology recommends follow-up every 2-3 years 1
• The European Society of Cardiology recommends annual echocardiography for severe mitral regurgitation 1
• For moderate mitral regurgitation with preserved LV function, the European Society of Cardiology recommends follow-up every 2 years 1
• The European Society of Cardiology recommends follow-up every 3-5 years for mild mitral regurgitation 1
• For severe tricuspid valve disease, the European Society of Cardiology recommends annual reassessment 1
• The European Society of Cardiology recommends initial baseline echocardiogram within 4-6 weeks after valve implantation 1
• For mechanical valve prostheses, the European Society of Cardiology recommends no routine annual echocardiography if the baseline study is normal and there is no change in clinical status 1
• For bioprosthetic valves, the European Society of Cardiology recommends annual echocardiography starting 5 years after implantation due to risk of degeneration 1
• The European Society of Cardiology recommends earlier evaluation for patients at higher risk of bioprosthetic valve degeneration, such as those with renal impairment, diabetes mellitus, abnormal calcium metabolism, systemic inflammatory disease, or age <60 years 1
• For hypertrophic cardiomyopathy, the European Society of Cardiology recommends annual or bi-annual echocardiography 2
• For dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and restrictive cardiomyopathy, the European Society of Cardiology recommends annual echocardiography, though specific evidence-based guidelines are lacking 2
• For reversible cardiomyopathies, such as peripartum, tachycardia-induced, or Tako-tsubo, the European Society of Cardiology recommends follow-up at 3 and/or 6 months 2
• For infective endocarditis, the European Society of Cardiology recommends no routine repeat echocardiography in stable patients, but recommends it at discharge as a baseline for future comparisons 2
• For bicuspid aortic valve with normal aortic root, the European Society of Cardiology recommends annual echocardiography 1
• For pericardial effusion, the European Society of Cardiology recommends frequency guided by clinical status 2
• For radiotherapy-induced heart disease, the European Society of Cardiology recommends echocardiography 5 years after exposure in high-risk patients, 10 years after exposure in others 2

Special Considerations

• The European Society of Cardiology recommends pre-pregnancy evaluation of valve function, ventricular size/function, and pulmonary pressures for patients with valve disease 1
• For left-sided stenotic lesions during pregnancy, the European Society of Cardiology recommends monthly echocardiography 1
• For regurgitant lesions during pregnancy, the European Society of Cardiology recommends individualized frequency 1
• For mechanical prostheses during pregnancy, the European Society of Cardiology recommends monthly echocardiography 1

Clinical Status Changes

• The American Heart Association recommends repeat echocardiography when symptoms develop or change, there is equivocal history of changing symptoms or exercise tolerance, or clinical findings suggest worsening of the condition 3
• For prosthetic valves, the European Society of Cardiology recommends repeat echocardiography on onset of heart failure, systemic thromboembolism, hemolysis, or new murmur 1

Echocardiography Frequency for Mild to Moderate Aortic Regurgitation

Surveillance Algorithm by AR Severity

• The American College of Cardiology recommends clinical visits annually with detailed history and physical examination to assess for symptom development in patients with mild aortic regurgitation 4, 5
• The American College of Cardiology recommends echocardiography every 2-3 years if the patient remains asymptomatic with stable left ventricular size and function in patients with mild aortic regurgitation 4, 5
• The European Society of Cardiology supports every 3-5 years echocardiography for truly mild aortic regurgitation 6, 7, 8
• The European Society of Cardiology recommends clinical visits every 1-2 years with comprehensive assessment of functional capacity and cardiac examination in patients with moderate aortic regurgitation 6, 7, 8
• The European Society of Cardiology recommends echocardiography every 1-2 years to monitor for progression to severe AR and assess left ventricular remodeling in patients with moderate aortic regurgitation 6, 7, 8

Key Parameters to Monitor at Each Echocardiogram

• Quantify effective regurgitant orifice area (EROA) and regurgitant volume (RVol) using Doppler methods, as these predict progression better than qualitative grading, according to the American College of Cardiology 4, 5
• Measure vena contracta width (≥0.6 cm indicates severe AR), according to the American College of Cardiology 4, 5
• Assess left ventricular end-diastolic dimension and end-systolic dimension to detect chamber remodeling, according to the American College of Cardiology 4, 5
• Evaluate left ventricular ejection fraction to identify early systolic dysfunction, according to the American College of Cardiology 4, 5

Critical Triggers for Earlier Repeat Echocardiography

• Perform echocardiography sooner than the scheduled interval if new or worsening symptoms develop, including dyspnea, reduced exercise tolerance, or chest pain, according to the American College of Cardiology 4, 5
• Perform echocardiography sooner than the scheduled interval if clinical examination findings suggest progression, such as widening pulse pressure, new diastolic murmur characteristics, or signs of heart failure, according to the American College of Cardiology 4, 5

Special Considerations

• If aortic root dilatation is present, serial echocardiograms are indicated to evaluate both aortic root size and AR severity, according to the American College of Cardiology 4, 5
• The 2022 systematic review of international guidelines shows consensus across ACC/AHA, ESC, and JCS societies supporting these surveillance intervals, according to the European Society of Cardiology 6, 7, 8

Echocardiography Recommendations for Patients with Normal Ventricular Function and Mild Valve Disease

Guideline-Based Recommendations

• The European Heart Journal guidelines recommend against routine repeat echocardiography in patients with normal ventricular function and trivial valve disease, unless there is a change in clinical status or treatment 9, 10, 11
• For patients with mild left ventricular hypertrophy (LVH) and normal ejection fraction (EF), no routine echocardiographic surveillance is needed in the absence of symptoms or clinical deterioration, according to the European Heart Journal guidelines 10, 11
• The European Heart Journal guidelines explicitly state that routine repeat assessment of ventricular function in the absence of changing clinical status or a change in treatment is not warranted, emphasizing the importance of clinical surveillance over routine imaging 10
• Clinical surveillance rather than routine imaging is strongly supported by evidence, as unnecessary repeat echocardiography does not improve outcomes and represents inappropriate resource utilization, as stated by the European Heart Journal guidelines 9, 10, 11

Critical Triggers for Earlier Echocardiography

• The European Heart Journal guidelines recommend obtaining a repeat echocardiogram if new or worsening symptoms develop, such as shortness of breath, reduced exercise tolerance, chest pain, palpitations, or syncope 11